Bridging the Gap: Integrating Quantitative Systems Pharmacology and Pharmacometrics in Drug Development Publication Bridging the Gap: Integrating Quantitative Systems Pharmacology and Pharmacometrics in Drug Development Quantitative Systems Pharmacology (QSP) and Pharmacometrics (PMX) have historically existed at the two ends of…CertaraJanuary 7, 2026
Explore Smarter, Faster PK/PD with Phoenix Webinar Explore Smarter, Faster PK/PD with Phoenix -CertaraJanuary 5, 2026
Add Off-target Risk Profiling to Your Analyses Fact Sheet Add Off-target Risk Profiling to Your Analyses Certara's cheminformatics solution, D360, supports a key feature of Secondary Intelligence: a low-medium-high ranking of…CertaraJanuary 5, 2026
Efficient creation of Tables, Figures & Listings with Certara’s Phoenix Cloud TFL Studio APAC Webinar Webinar Efficient creation of Tables, Figures & Listings with Certara’s Phoenix Cloud TFL Studio APAC Webinar CertaraJanuary 5, 2026
Delivering on Deadline: Why Pharmacometrics (PMx) Is the Anchor of Successful Regulatory Submissions Blog Delivering on Deadline: Why Pharmacometrics (PMx) Is the Anchor of Successful Regulatory Submissions Explore how PMx regulatory submissions, exposure-response modeling, and strategic pharmacometrics planning support successful and timely…CertaraDecember 29, 2025
Strategic Project Management for Accelerated Drug Development Fact Sheet Strategic Project Management for Accelerated Drug Development Expert project leadership to keep complex programs on track, aligned, and moving forward—so you can…CertaraDecember 23, 2025
Alternative parameters in NCA using Phoenix WinNonlin Webinar Alternative parameters in NCA using Phoenix WinNonlin CertaraDecember 22, 2025
A Systematic Review and Model-Based Meta-Analysis of Pegylated-Interferon-α-Induced HBsAg Loss in Chronic Hepatitis B Virus Infection Publication A Systematic Review and Model-Based Meta-Analysis of Pegylated-Interferon-α-Induced HBsAg Loss in Chronic Hepatitis B Virus Infection This study synthesizes data from a large body of clinical trials to evaluate rates of…CertaraDecember 18, 2025